Newova 2.5 mg Tablet
  1. Home
  2. Pharma Products
  3. Akumentis Healthcare Ltd
  4. Newova 2.5 mg Tablet

Newova 2.5 mg Tablet

Newova 2.5 mg Tablet contains letrozole, an aromatase inhibitor used mainly to treat hormone-sensitive breast cancer in postmenopausal women. It is an oral tablet containing 2.5 mg of letrozole. It may also be prescribed for infertility caused by anovulation under medical supervision.

BUY NOW

Category

Letrozole lowers estrogen production by inhibiting the aromatase enzyme, which can help slow the growth of estrogen-dependent breast cancer cells. It may be used as initial treatment or after other hormonal therapy in appropriate postmenopausal patients. In fertility treatment, letrozole can stimulate ovulation in women with anovulatory infertility when prescribed for this purpose. Treatment duration and dosing should be determined by the treating specialist based on the patient’s condition and response.

Technical Specification

Specification Details
Active Ingredient Letrozole
Strength 2.5 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 5 Tablets
Manufacturer Akumentis Healthcare Ltd

Product Also Known As

Newova 2.5 mg Tablet, Letrozole 2.5 mg Tablet, Newova Letrozole Tablet, Letrozole Anticancer Tablet, Newova Breast Cancer Tablet, Letrozole Aromatase Inhibitor Tablet

Related products